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Summary
The master transcription factors play integral roles in the pluripotency transcription circuitry of
embryonic stem cells (ESCs). How they selectively activate expression of the pluripotency
network while simultaneously repressing genes involved in differentiation is not fully understood.
Here we define a requirement for the INO80 complex, a SWI/SNF family chromatin remodeler, in
ESC self-renewal, somatic cell reprogramming, and blastocyst development. We show that Ino80,
the chromatin remodeling ATPase, co-occupies pluripotency gene promoters with the master
transcription factors, and its occupancy is dependent on Oct4 and Wdr5. At the pluripotency
genes, Ino80 maintains open chromatin architecture and licenses recruitment of Mediator and
RNA Polymerase II for gene activation. Our data reveal an essential role for INO80 in the
expression of the pluripotency network, and illustrate the coordination among chromatin
remodeler, transcription factor, and histone modifying enzyme in the regulation of the pluripotent
state.
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Embryonic stem cells (ESCs) are derived from the inner cell mass (ICM) of blastocyst stage
embryos. They have two defining features: the ability to become any other cell type, known
as pluripotency, and the ability to proliferate indefinitely while maintaining the pluripotent
state, known as self-renewal. At the transcriptional level, ESC self-renewal and pluripotency
is maintained by a highly orchestrated gene expression program (Dejosez and Zwaka, 2012;
Jaenisch and Young, 2008; Ng and Surani, 2011; Young, 2011). The regulators of this
program can activate, repress, or establish a poised state for gene expression. Master ESC
transcription factors Oct4, Nanog, and Sox2 form the core of the pluripotency transcription
network. They form a self-regulatory loop, and activate pluripotency genes while repressing
those involved in differentiation (Boyer et al., 2005). Many other pluripotency factors
further modulate and refine the core circuitry and augment the function of Oct4, Nanog, and
Sox2 (Chen et al., 2008; Kim et al., 2008). How the master transcription factors act
differently to activate ESC and repress differentiation genes is not clear.
In addition to transcription factors, recent studies indicate that the chromatin of ESCs has a
unique open conformation, which likely contributes to self-renewal and pluripotency by
providing an appropriate environment for gene expression (Mattout and Meshorer, 2010).
Indeed, ESCs are highly sensitive to reduced levels of chromatin architectural proteins such
as Cohesin and Mediator (Kagey et al., 2010). They are also sensitive to the depletion of
chromatin regulators such as histone modifying enzymes and chromatin remodelers (Fazzio
et al., 2008; Gaspar-Maia et al., 2009; Ho et al., 2011; Kidder et al., 2009; Landry et al.,
2008; Schaniel et al., 2009; Singhal et al., 2010). While the complex interplay of the master
ESC transcription factors with chromatin regulators is a focus of intense investigation, much
remains to be learned.
Of the chromatin regulators, the ATP-dependent chromatin-remodeling complexes can
move, eject, or restructure nucleosome composition and dynamics (Clapier and Cairns,
2009; Hargreaves and Crabtree, 2011). As a result, they play a central role in gene
regulation by controlling the packing and unpacking of the chromatin to provide regulated
DNA accessibility. Several chromatin remodelers, including Chd1, Chd7, esBAF, and
Tip60-p400, have been studied in ESCs (Fazzio et al., 2008; Gaspar-Maia et al., 2009; Ho et
al., 2011; Kidder et al., 2009; Schnetz et al., 2010), providing insights into how these factors
contribute to ESC biology. However, little is known regarding how the master ESC
transcription factors themselves utilize chromatin remodeling factors to selectively activate
the genes required for self-renewal and pluripotency.
We and others have previously identified the INO80 complex as a novel self-renewal factor
in RNAi screens (Chia et al., 2010; Hu et al., 2009). INO80 belongs to the INO80 subfamily
of the SWI/SNF chromatin remodeling complexes. Although it is known to function in a
variety of nuclear transactions, including transcription regulation, DNA repair, and DNA
replication (Conaway and Conaway, 2009; Morrison and Shen, 2009; Watanabe and
Peterson, 2011), its role in ESCs remains undefined. Here we show that the INO80
chromatin remodeling complex is required for ESC self-renewal, as well as for
reprogramming and embryonic development. INO80 selectively occupies promoters of core
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pluripotency genes bound by the master ESC transcription factors, but not those involved in
differentiation, and its occupancy is dependent on Oct4 and Wdr5. Importantly, INO80
maintains accessible chromatin architecture and facilitates recruitment of Mediator and
RNA polymerase II at these genes, promoting their expression. These results define an
essential role for the INO80 complex in the establishment and maintenance of the
pluripotent state through its specific action on a core network of pluripotency genes.
Results
INO80 is important for ESC self-renewal
To define the role of INO80 in ESCs, we silenced individual subunits of INO80 with
siRNAs. Using the Oct4GiP reporter ESCs (Ying and Smith, 2003; Zheng and Hu, 2012), in
which the expression of the enhanced green fluorescent protein (EGFP) is driven by the
ESC-specific Oct4 promoter, we found that silencing of all the tested subunits (Figure S1A)
resulted in ESC differentiation as evidenced by the loss of EGFP expression (Figure 1A).
Furthermore, INO80 silencing also led to the loss of typical ESC morphology (Figure 1B),
suggesting that it plays an essential role in ESC maintenance.
As Ino80 is the SWI/SNF ATPase in the complex and its knockdown (KD) led to the most
pronounced phenotype (Figure 1A, 1B), we chose to focus on this specific subunit to
elucidate the role of the INO80 complex in ESCs. Consistent with the above results, Ino80
KD led to the loss of alkaline phosphatase (an ESC marker) staining (Figure S1B).
Furthermore, it led to decreased expression of key pluripotency factors including Oct4,
Nanog, Sox2, Klf4 and Esrrb, as well as increased expression of lineage markers such as
Cdx2, Fgf5, Nestin and Pax3 (Figure 1C and 1D). To minimize the possibility of the off-
target effect, we used 2 siRNAs and 3 shRNAs for Ino80 silencing. In all cases, Ino80
silencing led to similar changes in pluripotency marker expression (Fig. S1C, S1D). Thus,
Ino80 is required for ESC self-renewal.
In agreement with its role in self-renewal, Ino80 is down-regulated during ESC
differentiation, similar to the ESC marker Oct4 (Figure 1E). In addition, it is expressed at
higher levels in ESCs compared to other cell types, such as trophoblast stem cells (TSCs)
and mouse embryonic fibroblasts (MEFs) (Figure S2). Interestingly, analysis of published
chromatin immunoprecipitation (ChIP) datasets showed that key pluripotency factors such
as Oct4, Nanog, Sox2, Klf4, and Esrrb co-occupy regions near the Ino80 transcription start
site (TSS) (Figure 1F). Moreover, Oct4 or Sox2 KD resulted in significant down-regulation
of Ino80 within 48 hours (Figure 1G). Collectively, these results strongly suggest that Ino80
expression correlates with the ESC state and is tightly regulated by pluripotency factors.
INO80 is required for pluripotency gene expression
To understand how the INO80 complex regulates self-renewal and pluripotency, we carried
out microarray analysis upon silencing of individual subunits in ESCs. Ino80, Ino80b,
Ino80c and Ino80e KD induced expression changes of 2406, 1845, 1810 and 1276 genes,
respectively. Overlap analysis indicated that 440 genes had altered expression patterns no
matter which subunit was silenced (Figure 2A). Surprisingly, the overwhelming majority of
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these genes (407 of the 440) were down-regulated following depletion of INO80 subunits,
suggesting that the INO80 complex may function to sustain their expression. Furthermore,
this gene set included key pluripotency genes such as Oct4, Nanog, Klf4, Esrrb, Tcl1, Tbx3
and Foxd3 (Figure S3A–B), suggesting that INO80 is required for the expression of
pluripotency factors in ESCs.
To monitor the dynamic gene expression changes upon Ino80 KD, we performed microarray
analysis at days 2, 4 and 6 after silencing the ATPase Ino80 with a lentiviral-based shRNA.
Consistent with the above results using siRNAs, Ino80 KD by shRNA induced down-
regulation of almost all the well-characterized pluripotency factors over time, including
Oct4, Nanog, Sox2, Klf4, Esrrb, Tcl1, Tbx3, Nr0b1, Nr5a2, Foxd3, Zfp42, and Tet1 (Figure
2B, S3C). Furthermore, Ingenuity pathway analysis (IPA) indicated that Ino80-regulated
genes are highly enriched for pluripotency factors (Figure S3D), and gene set enrichment
analysis (GSEA) showed that genes down-regulated after Ino80 KD are highly enriched for
genes that are down-regulated during ESC differentiation (Figure 2C). In contrast, the vast
majority of housekeeping genes were not down-regulated after Ino80 silencing (Figure S3E–
F).
To understand how Ino80 fits into the pluripotency transcription network, we next compared
the gene expression changes caused by Ino80 KD with those caused by the depletion of
other pluripotency factors. Ino80 KD clustered with Oct4, Sox2, and Nanog (Figure 2D),
suggesting that similar to those master transcription factors Ino80 plays a critical role in
maintaining the gene expression program in ESCs. Together, these results support the notion
that the INO80 complex is an important component of the pluripotency transcription
circuitry and is required for the expression of pluripotency factors.
Ino80 occupies pluripotency gene promoter proximal regions
The fact that key pluripotency factors such as Oct4, Nanog, Sox2, Klf4, and Esrrb were
quickly down-regulated after INO80 silencing (Figure 2B, S3A–C) suggested that INO80
may directly regulate their expression. To test this hypothesis, we performed chromatin
immunoprecipitation followed by high through-put sequencing (ChIP-seq) and identified
12,749 genomic regions occupied by Ino80 with high confidence (FDR = 10−6). The Ino80
peaks were enriched in gene-rich chromosomal regions where they tended to co-localize
with transcription start sites (TSS) (Figure 2E, S4A) as has been observed in yeast (Yen,
2013). Interestingly, Ino80 peaks co-localized with active histone marks including
H3K4me3 and H3K27ac, but not inactive chromatin marks such as H3K27me3. They also
closely co-localized with the master ESC transcription factors Oct4, Nanog, and Sox2
(Figure 2F, S4B). Inspection of individual gene tracks and ChIP followed by quantitative
PCR (ChIP-qPCR) showed that Ino80 occupied genomic regions near well-characterized
pluripotency genes, including the master ESC transcription factors (Figure 2G). Of the 2126
genes that showed differential expression after Ino80 KD, 678 had Ino80 occupancy nearby
and were likely its direct targets (Figure 2H). These Ino80 target genes included nearly all
the key pluripotency factors and were strongly enriched for genes involved in ESC self-
renewal and pluripotency (Figure 2H, 2I).
Wang et al. Page 4






















Notably, while many Ino80-occupied genes were co-occupied by master ESC transcription
factors Oct4, Nanog, and Sox2, the converse statement was not true. A significantly smaller
fraction of the Oct4, Nanog, or Sox2-bound genes were co-occupied by Ino80 (Figure 3A
and S4B). GSEA indicated that Ino80-occupied genes were mostly down-regulated during
ESC differentiation (Figure 3A, 3B), consistent with the idea that INO80 facilitates
expression at these loci and may function as an activator (Figure 2A). In contrast, Oct4,
Nanog, and Sox2-bound genes were either up-regulated or down-regulated during
differentiation (Figure 3A, S4C). As Oct4, Nanog, and Sox2 are known to maintain self-
renewal by activating ESC genes and repressing differentiation genes, our data suggest that
Ino80 is required for the master transcription factors to activate pluripotency genes integral
to the ESC state. In agreement with this, genes co-occupied by Ino80, Oct4, Nanog, and
Sox2 are highly enriched for pluripotency genes and tend to be down-regulated during
differentiation (Figure 3C, S4D–E, Table S5). Genes co-occupied by Oct4, Nanog, Sox2 but
not Ino80 are enriched for developmental and differentiation-associated genes and are more
likely to be up-regulated during differentiation (Figure 3C, S4D–E, Table S5).
To understand how Ino80 is recruited to pluripotency genes promoters, we searched for
factors that are required for its genomic occupancy. As chromatin regulators are often
recruited by pioneer factors, we hypothesized that Ino80 may be recruited by master ESC
transcription factors. Indeed, it has been reported that Oct4 interacts with Ino80 (Pardo et al.,
2010), and we confirmed the interaction by immunoprecipitation (Figure 3D). To test our
hypothesis, we used the ZHBTc4 cells in which Oct4 expression can be repressed by
Doxycycline treatment (Niwa et al., 2000). We found that Oct4 depletion by 48 hrs of
Doxycycline treatment led to a profound reduction in Ino80 occupancy near pluripotency
gene promoters, with only a modest decrease in Ino80 expression (Figure 3E, 3F). This
result suggested that Oct4 is important for Ino80 recruitment. However, we reasoned that
there may be additional factor(s) involved, as Ino80 occupancy was not abolished in Oct4
depleted cells and Ino80 only occupies a small subset of genes that are occupied by Oct4. To
search for the additional factor(s), we carried out Ino80 immunoprecipitation (IP) followed
by Mass-spectrometry, and found that Ino80 interacts with another known pluripotency
protein Wdr5 (data not shown). We confirmed this interaction by IP-western (Figure 3D,
S4F). Wdr5 is a key component of the H3K4 methyltransferase complex. It occupies
actively transcribed genes in ESCs and is required for self-renewal (Ang et al., 2011). To
test its role in Ino80 recruitment, we silenced Wdr5 with shRNAs. At 48 hrs, Wdr5 silencing
significantly reduced Ino80 genomic occupancy without affecting its expression (Figure 3G,
3H). Thus, Ino80 occupancy is dependent on both Oct4 and Wdr5. As Oct4 and Wdr5
occupy developmental genes and actively transcribed genes, respectively, they may
cooperatively facilitate the recruitment of Ino80 to pluripotency gene promoters. Consistent
with this notion, there is a significant overlap between genes co-occupied by Oct4 and Wdr5
and those occupied by Ino80 (Figure 3I). However, there are likely other factors involved in
the recruitment of Ino80, as Oct4 and Wdr5 occupy both promoter and enhancer regions
while Ino80 preferentially occupy promoter regions.
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INO80 promotes Mediator and Pol II recruitment
Our results indicate that INO80 is required for pluripotency gene expression. We therefore
hypothesize that INO80 may activate pluripotency genes by recruiting factors necessary for
their transcription. Consistent with this idea, we found that Ino80 occupancy at promoter
proximal regions strongly correlates with occupancy of factors important in ESC gene
expression and self-renewal, such as Oct4, Nanog, Sox2, Esrrb, Klf4, and Med1 (Figure 4A,
4B, S5A–B). To test whether INO80 occupancy affects the recruitment of these factors, we
carried out ChIP-seq for Oct4, Klf4, and Med1 48 hours after Ino80 shRNA virus
transduction. At this time point, Ino80 silencing led to significant down-regulation of Ino80
protein, but only subtle decreases in pluripotency mRNA and protein levels and a slight up-
regulation of Med1 level (Figure S5C, S5D). However, Ino80 silencing led to an obvious
reduction in Med1 binding at Ino80 and Med1 co-occupied TSS regions (Figure 4C, 4D).
Furthermore, Med1 binding was reduced near genes that were down-regulated after Ino80
silencing (Figure 4E, 4F). In contrast, Ino80 silencing did not cause a similar decrease in
Oct4 or Klf4 binding (Figure 4C, 4D). Oct4 binding was even slightly increased, consistent
with a recent report that slightly reduced Oct4 level increases its occupancy (Karwacki-
Neisius et al., 2013). Thus, Ino80 does not appear to directly regulate the recruitment of
pluripotency transcription factors. Examination of individual gene tracks and ChIP-qPCR
confirmed that Ino80 silencing caused significant reduction of Mediator binding near key
pluripotency gene promoter regions (Figure 4G, 4H). As Mediator is essential for
transcription initiation (Ansari and Morse, 2013), our results suggest that INO80 may
normally promote pluripotency gene expression through the recruitment of Mediator.
Because Mediator loss-of-function has been found to compromise RNA polymerase II
association with promoters of active genes in other cell types (Ansari and Morse, 2013), we
next examined whether Ino80 silencing and impaired Med1 recruitment has an impact on
Pol II occupancy. Based on ChIP-seq, Ino80 silencing led to decreased binding of Pol II near
promoters occupied by Ino80 (Figure 5A, 5B), as well as promoters of genes down-
regulated after Ino80 silencing (Figure 5C, 5D). This result was confirmed by ChIP-qPCR at
the Oct4, Nanog, Sox2, and Klf4 promoters (Figure 5E). Importantly, Ino80, Med1, and Pol
II co-occupied genes were highly enriched for those that are down-regulated during ESC
differentiation into EBs (Figure 5F), and they were also mostly down-regulated during
differentiation (Figure 5G). Together, our data suggest that INO80 activates pluripotency
genes by facilitating the recruitment of Mediator and Pol II at their promoters.
INO80 maintains an open chromatin structure
Recent work in yeast has demonstrated a striking association of INO80-family chromatin
remodelers with nucleosome depleted regions around transcription start sites where it
participates in H2A/H2A.Z exchange and nucleosome turnover (Ranjan et al., 2013; Yen et
al., 2013). We hypothesized that physical occupancy of these regions by INO80 might
preclude stable nucleosome formation in these regions at bound loci, leaving DNA in and
around the TSS more accessible to the general transcription machinery, Mediator, and RNA
pol II. Thus, we evaluated the nucleosome occupancy in the presence or absence of Ino80 by
micrococcal nuclease (MNase) digestion and PCR at selected regions. Whereas no effect
was observed on genomic regions that are only occupied by ESC master transcription
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factors, nucleosome occupancy at regions co-occupied by Ino80 and master transcription
factors was greatly increased at 48 hrs of Ino80 KD (Figure 6A). Consistent with that
observation, Ino80 binding sites resided in nucleosome-depleted regions in ESCs (Figure
6B). In contrast, the overall Oct4 occupied regions were not associated with nucleosome
depletion (Figure 6B), but those that were co-occupied by Ino80 showed some depletion
(Figure S5E). To determine how Ino80-mediated nucleosome depletion affects genome
accessibility, we carried out DNase I sensitivity assay for selected regions in the presence or
absence of Ino80. Ino80 depletion led to reduced DNase I sensitivity at regions co-occupied
by Ino80 and ESC master transcription factors, but had no effect on those only occupied by
master transcription factors (Figure 6C). In agreement with that, almost all Ino80 bound
regions (12470 out of 12749, 97.81%) overlapped with DNase I hypersensitive sites (Figure
6D), and Ino80 occupancy positively correlated with DNase I hypersensitivity (Figure 6E).
These data suggest that INO80 maintains an open chromatin structure near pluripotency
genes.
To test whether Ino80-mediated open chromatin structure facilitates the activation of the
neighboring gene, we cloned DNA fragments occupied by Ino80 in ESCs into a luciferase
reporter construct (Whyte et al., 2013) and transfected the reporter constructs into ESCs.
DNA fragments corresponding to Ino80 peaks in ESCs strongly enhanced the reporter
expression (Figure 6F). More importantly, the reporter expression was markedly suppressed
by Ino80 KD (Figure 6G). In comparison, the activities of genomic regions occupied by
Oct4, Nanog, Sox2 but not Ino80 were not inhibited by Ino80 KD in the same test (Figure
6G). Collectively, our data suggest that the INO80 complex may regulate pluripotency gene
expression by maintaining an open chromatin structure.
INO80 is required for reprogramming and blastocyst formation
During the course of reprogramming, pluripotency is established through the activation of
the ESC gene expression program, as well as the establishment of ESC-specific chromatin
structure (Stadtfeld and Hochedlinger, 2010). Given the essential role of the INO80 complex
in ESC maintenance, we asked whether it also has a role in the establishment of
pluripotency. We first tested the function of Ino80 in the reprogramming of somatic cells
into induced pluripotent stem cells (iPSCs). Ino80 expression quickly increased during the
course of reprogramming and reached its highest level on day 6, coinciding with the time
when the endogenous pluripotency genes start to become activated (Polo et al., 2012)
(Figure 7A). More importantly, Ino80 silencing by shRNA dramatically reduced the number
of alkaline phosphatase-positive iPSC colonies formed after reprogramming (Figure 7B,
S6A). In comparison, Ino80 KD did not reduce the expression of housekeeping genes
(Figure S6B) and only modestly affected the growth of MEFs (Figure S6C). To confirm the
above results, we carried out the reprogramming assay in MEFs that harbor a reporter EGFP
gene under the control of the Oct4 promoter. Ino80 silencing did not impair the expression
of the reprogramming factors (Figure S6D), but caused a significant reduction in the number
of EGFP-positive iPSCs (Figure 7C, 7D). Furthermore, Ino80 silencing resulted in reduced
expression of early markers of reprogramming at day 6 (Figure 7E). It also resulted in a
more closed chromatin structure near pluripotency gene promoters, as evidenced by
increased nucleosome occupancy (Figure S7A) as well as decreased H3K4me3 and
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increased H3K27me3 occupancy (Figure S7B–C). Therefore, Ino80 is required for efficient
somatic cell reprogramming in vitro, possibly by activating pluripotency gene expression.
Next, we assessed the role of INO80 in blastocyst development, as the inner cell mass (ICM)
specification during blastocyst formation also requires the establishment of pluripotency
(Nichols and Smith, 2012). By RT-qPCR, we found that Ino80 expression gradually
increased during early embryonic development and was highest at the blastocyst stage
(Figure 7F). Immunofluorescence staining confirmed that Ino80 was expressed in ICM and
localized in the nucleus, consistent with its function in ESCs (Figure 7G). We tested the
antibody specificity toward Ino80 by carrying out staining in ESCs as well as in embryos
treated with control- or Ino80-siRNAs, and confirmed that the antibody specifically
recognizes Ino80 (Figure S7D, S7E). To test the role of INO80 during blastocyst
development, we injected Ino80 siRNA into one-cell embryos, and cultured the embryos ex
vivo to allow development to proceed. Visual inspection of the embryos indicated that Ino80
KD significantly inhibited blastocyst formation (Figure 7H, 7I). RT-qPCR confirmed that
siRNA injection effectively silenced Ino80 (Figure 7J). Furthermore, in the few blastocysts
formed from the Ino80-siRNA injected embryos, the expression of Oct4, Nanog, Sox2, and
Klf4 was dramatically reduced (Figure 7K). Therefore, Ino80 is required for blastocyst
development ex vivo, in part by maintaining the proper expression of pluripotency genes.
Together with our results in ESCs and iPSCs, we propose that Ino80 is required for the
establishment of pluripotency both in vitro and in vivo.
Discussion
In this study, we show that the INO80 complex is required for both the establishment and
maintenance of pluripotency and is a key component in the core pluripotency transcription
circuitry. Our data support the model that INO80 occupies pluripotency gene promoter
proximal regions and activates their expression by maintaining an open chromatin structure
and facilitating the recruitment of Mediator and Pol II.
Although several chromatin remodeling complexes were previously implicated in ESC
biology, their roles in the core ESC transcription circuitry have not been clearly defined. For
example, CHD1 regulates open chromatin and the differentiation capacity of ESCs (Gaspar-
Maia et al., 2009). Tip60-p400 represses differentiation genes to maintain ESC identity
(Fazzio et al., 2008). esBAF facilitates LIF/STAT3 signaling and regulates polycomb
function (Ho et al.). NuRD represses pluripotency genes to promote transcriptional
heterogeneity and lineage commitment (Hu and Wade, 2012; Reynolds et al., 2012). In
contrast, we show that INO80 forms an auto-regulatory loop with the master ESC
transcription factors Oct4, Nanog, and Sox2. More importantly, it specifically activates
pluripotency genes with the master transcription factors to maintain the ESC state.
Consistent with this notion, of all the chromatin remodelers, only INO80 was identified as a
self-renewal regulator in the Oct4-reporter based RNAi screens (Chia et al., 2010; Ding et
al., 2009; Fazzio et al., 2008; Hu et al., 2009), possibly because of its role in the direct
regulation of the core pluripotency circuitry.
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Mechanistically, it has been proposed that INO80 can regulate transcription via the ATP-
dependent mobilization of nucleosomes (Conaway and Conaway, 2009; Shen et al., 2000;
Watanabe and Peterson, 2011). In agreement with this model, our data indicate that INO80
is required for the maintenance of nucleosome depleted regions and open chromatin
structure at the pluripotency gene promoters. Alternative models posit that INO80 regulates
the distribution of the histone variant H2A.Z and promotes H2A.Z eviction from promoters
(Papamichos-Chronakis et al., 2011). Indeed, INO80 occupies nucleosome-free regions
around transcription start sites in yeast, where it promotes H2A/H2A.Z exchange and
nucleosome turnover (Ranjan et al., 2013; Yen et al., 2013). In ESCs, H2A.Z is highly
enriched at active and bivalent promoters (Hu et al., 2013; Ku et al., 2012). It is post-
translationally modified and distinct modification states enables H2A.Z to regulate different
class of genes, such as active and poised genes (Ku et al., 2012). Thus, it is conceivable that
INO80 may be required for pluripotency gene expression by promoting the cycling of
H2A.Z and/or modified H2A.Z at their promoters, facilitating the maintenance of the
nucleosome-depleted regions and the accessibility of the general transcription factors.
Consistent with this model, our data demonstrate that INO80 occupancy enhances the
recruitment of Mediator and Pol II, and thus activates target gene expression. Mediator
interacts with Pol II and the general transcription machinery, coordinating the assembly of
the general initiation factors and chromatin machinery into functional pre-initiation
complexes (Ansari and Morse, 2013), (Chen et al., 2012). In addition, Mediator is required
for the maintenance of ESC identity (Kagey et al., 2010) by forming dense clusters near
pluripotency genes to regulate their expression (Whyte et al., 2013). It promotes long-range
chromatin interactions at these genes and plays an important role in genome organization in
ESCs and reprogramming (Apostolou et al., 2013; Denholtz et al., 2013; Wei et al., 2013;
Zhang et al., 2013). However, it is not fully understood how Mediator recognizes
pluripotency genes. Our findings suggest that INO80 may act upstream of Mediator for its
recruitment to ESC genes and regulate the unique chromatin organization in ESCs.
Finally, the master transcription factors occupy genomic regions near both ESC and
differentiation genes (Dejosez and Zwaka, 2012; Jaenisch and Young, 2008; Ng and Surani,
2011; Young, 2011), and it is not clear how they selectively activate ESC genes to maintain
the ESC state. Our results suggest that INO80 preferentially occupies ESC genes promoters,
and its occupancy is dependent on both the master transcription factor Oct4 and the H3K4
methyltransferase complex component Wdr5. As Oct4 regulates developmental genes while
Wdr5 regulates actively transcribed genes in ESCs, we propose that INO80 integrates the
input from Oct4 and Wdr5 to specifically regulate pluripotency gene expression. It therefore
acts as a deterministic factor in the transcriptional outcome for genes regulated by the master
transcription factors. Thus, our findings elucidate a previously unrecognized coordination
between INO80, the master transcription factors, and a histone modifying enzyme in
controlling the pluripotent state, and shed light on how chromatin remodelers can orchestrate
sophisticated transcriptional regulation in cell fate decision with other factors.
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Mouse ESC Culture, Differentiation, and Transfection
J1 ESCs were obtained from the American Type Culture Collection. ZHBTc4 cells are
kindly provided by Dr. Hitoshi Niwa. They were cultured on gelatin-coated plates in the
ESGRO complete plus clonal grade medium (for maintenance) or the M15 medium (for
experiments) as described before (Zheng et al., 2012). M15 medium contains DMEM
supplemented with 15% FBS, 10 μM 2-mercaptoethanol, 1 mM nonessential amino acids, 1
× EmbryoMax nucleosides, 1000 U/ml of LIF (Millipore). ESC differentiation and
transfections were carried out similarly as described previously (Wang et al., 2013).
Oct4GiP Reporter Assay
Oct4GiP ESCs were kindly provided by Dr. Austin Smith. Oct4GiP reporter assay was
carried out as described previously (Zheng and Hu, 2012).
TSC culture
Mouse TSCs were kindly provided by Dr. Janet Rossant, and were cultured based on the
published protocol without feeders (Rossant, 2006).
Immunofluorescence Staining
Cells were stained with primary antibodies against Ino80 (1:100, Proteintech), Cdx2 (1:100,
Cell Signaling) or Oct4 (1:100, Santa Cruz), and cell nuclei were counterstained with DAPI
(Invitrogen). Confocal images were taken on the Zeiss LSM 710 microscope.
Mouse blastocyst stage embryos were collected at E3.5, and incubated with primary
antibody against Ino80 (1:300) and then secondary antibody (Alexa Fluor® 594, goat anti-
rabbit IgG, 1:1000, Life Technologies). The embryos were stained with DAPI to identify
cell nuclei. Confocal images were taken on the Zeiss LSM 710 microscope.
RNA Isolation, Reverse Transcription and Real-time PCR
Total RNA was isolated from cells using the GeneJet RNA purification kit (Thermo
Scientific), and 0.5 μg total RNA was reverse transcribed to generate cDNA using the
iScript™ cDNA Synthesis Kit (Bio-Rad) according to manufacturer’s instructions. qPCRs
were performed using the SsoFast™ EvaGreen® Supermix (Bio-Rad) on the Bio-Rad
CFX-384 or CFX-96 Real-Time PCR System. Actin was used for normalization. Primers
used in the study were listed in Table S1.
ChIP-qPCR and ChIP-Seq Sample Preparation
Ino80 ChIP was performed as described previously (Whyte et al., 2013). J1 cells were fixed
using 1% formaldehyde for 10 min, and followed by 0.125M glycine 5 min to stop the
fixation. Then the cells were harvested, and DNA was fragmented to 300–500 bp by
sonication with a microtip attached to Misonix 3000 sonicator. Immunoprecipitation was
performed with 3 μg Dynabeads protein G (Life Technology) conjugated-rabbit polyclonal
anti-Ino80 (Proteintech) antibody overnight at 4 °C. Afterwards, beads were washed, eluted
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and reverse cross-linked. DNA was extracted by phenol/chloroform and precipitated. The
resulting DNA was analyzed by qPCR and data were presented as the percentage of input
using indicated primers (Table S1). For Oct4, Klf4, Med1 and Pol II ChIP, J1 cells were
infected with non-targeting (NT) or Ino80 shRNA. 48 hours after infection, cells were
harvested for ChIP against Oct4 (Santa Cruz), Klf4 (R&D), Med1 (Bethyl) and Pol II (Santa
Cruz) based on the protocol described above. For ChIP-seq, 1 ng precipitated DNA or input
was used to generate DNA library by use of Nextera XT DNA sample preparation Kit
(Illumina) according to the manufacturer’s instruction. The resulting libraries were used for
sequencing by MiSeq (Illumina). Two biological replicates were performed here, and
combined reads were used for further analysis.
MNase qPCR
Nucleosome occupancy in ESCs was determined according to a published protocol (Wei et
al., 2012) with modifications. Nuclei were isolated from J1 ESCs. Native chromatin without
crosslinking was resuspended in digest buffer (15 mM Tris pH 8, 60 mM KCl, 15 mM NaCl,
1 mM CaCl2, 0.25 M sucrose, 0.5 mM DTT) and incubated with 40 units MNase for 5
minutes at room temperature. Digestion was stopped by adding stop buffer (0.5 ml 10%
SDS, 0.5 ml 1M NaBicarbonate, 0.2 ml 0.5 M EDTA, 3.8 ml H2O). Chromatin was
precipitated, and isolated using 1.2% DNA gel. Mononucleosomal DNA was collected and
extracted using a gel extraction kit (Qiagen). Nucleosome occupancy was evaluated by
qPCR and presented as percentage of input. Primers used in this assay are listed in Table S1.
DNase I Sensitivity Assay
DNase I sensitivity assay was performed as described previously (Ho et al., 2011) with
modifications. We added equal amount of Drosophila genomic DNA to each reactions as an
internal control to minimize the variations caused by phenol-chloroform extraction. The
same genomic regions assayed in the MNase qPCRs were examined for DNase I sensitivity
by qPCRs, and a region near the Drosophila Rps49 gene was used as internal control to
calculate the fold changes.
Luciferase Reporter Assay
Ino80 occupied regions were generated by PCR from E14 wide type genomic DNA. The
regions were cloned into pGL3-Promoter containing the minimal Oct4 promoter as
described previously (Whyte et al., 2013). Primers used for the cloning were listed in Table
S1.
Mouse Embryo Collection and Microinjection
CF-1 female mice were superovulated and mated to B6D2F1/J males, and one cell embryos
were collected. Microinjections were performed using a Leica DMI 6000B inverted
microscope equipped with a XenoWorks Micromanipulator system and a PrimeTech
PMM-150FU Piezo drill (Sutter Instruments). Five to ten picoliter of the 20 μM non-
targeting, or Ino80 siRNA was injected into the cytoplasm of one cell embryos. After
injection, the embryos were cultured and inspected at indicated time points to determine
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developmental progress. Each experiment consisted of three separate replicates, and
approximately 30 embryos were injected in each replicate.
Reprogramming
MEFs were plated in 12-well plate at 2 × 105 cells / well (day-0), and transduced with the
non-targeting or Ino80 pLKO.1 shRNA viruses the next day (day-1). 2 days after
transduction, cells were re-plated in 12-well plate at 80 k / well (day-3), and were transduced
with the STEMCCA viruses (Sommer et al., 2009) encoding the four Yamanaka factors the
next day (day-4). Cells were re-plated in gelatin-coated 12-well plates at 80 k / well at
day-5. On day-6, culture medium was switched from MEF medium to M15, and medium
was changed every day until colony number was counted by AP staining on day-14.
Microarray Analysis
J1 ESCs were transfected with siRNAs as described above in duplicates, and were collected
96 hrs after transfection. Gene expression analysis was carried out on the Agilent Whole
Mouse Genome 4 × 44k arrays following the Agilent 1-color microarray-based gene
expression analysis protocol. Data was processed in R-3.0.0 by first reading the Agilent files
using Bioconductor package Agi4x44PreProcess version 1.20.0. Data was reviewed using
MA-plots, and the “G” platform signal intensities were normalized so the median log2 fold
change was zero.
For the time course experiment, Ino80 shRNA sample groups were compared to non-
targeting shRNA control at each respective time point. For the subunit experiment, each
Ino80 subunit siRNA sample group was compared to the non-targeting siRNA sample
group. A statistical model was fit using the Bioconductor limma package version 3.16.1,
using the “duplicateeCorrelation” function as described in the Limma User Guide for probes
with technical replicates. Statistical comparisons were performed using a moderated t-test,
P-values adjusted using the Benjamini-Hochberg adjustment. Statistical hits were defined as
having adjusted P-value <= 0.05 and absolute fold change >= 1.5.
Statistical results were combined per-gene using the following logic: 1) For each gene
associated with only one probe, its results were used without modification; 2) For genes
associated with multiple microarray probes, results were combined using only the
statistically significant probes; 3) If multiple probes for a given gene were significant and
the fold changes were in opposing directions, the probes with the same direction as the most
significant probe were used; 4) If no probes were statistically significant, all probes for the
gene were used.
ChIP-Seq Data Analysis
Ino80 ChIP-seq and Input libraries were sequenced using MiSeq technologies at the NIEHS
DNA Sequencing Core. Standard Illumina CASAVA 1.8 utilities were used to
generate .fastq output files. All libraries were sequenced as single end 36mers. ChIP-Seq
datasets profiling the genomic occupancy of H3K4me3, H3K27me3, H3K27ac, Oct4, Sox2,
Nanog, Klf4, Med1, DNase I hypersensitivity, and nucleosome occupancy in mouse ESCs
were obtained from previous publications (Table S2).
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Sequenced reads from ChIP-seq and Input libraries were combined for replicate samples and
filtered as stated in text. Filtered reads were then aligned to the mouse reference genome
(NCBI build 37, mm9) using the Bowtie short-read alignment program (v0.12.8 employing
parameters -v2, -m1) to retain reads mapped to unique genomic locations with at most 2
mismatches. Only non-duplicate reads were used in subsequent peak calling analyses and
the generation of coverage tracks. To make the coverage tracks, aligned reads were extended
at the 3′ end to a length of 300 bases (the expected genomic fragment size) for Ino80 and
200 bases for other factors, and bigWig files were generated to visualize aggregate genomic
coverage. ChIP-seq peaks for each cell type were called using SICER (Zang et al., 2009)
with a FDR threshold of 1e-6 or 1e-20 and the following parameters (Ino80: redundancy
threshold=1, window size=200, gap size=600, fragment size=300; Other factors: Ino80:
redundancy threshold=1, window size=200, gap size=600, fragment size=200). Sequenced
reads from matched supernatant Inputs were used as controls for each cell type.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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INO80 is required for ESC self-renewal, reprogramming, and blastocyst
development
INO80 occupies pluripotency gene promoters, which is dependent on Wdr5 and
Oct4
INO80 maintains an open chromatin structure and recruits Mediator and Pol II
INO80 binding distinguishes active genes from those repressed by master TFs
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Figure 1. INO80 is Required for ESC Self-renewal
(A) The Oct4GiP reporter assay after silencing different INO80 subunits. NT: non-targeting
siRNA as negative control. % Differentiation was plotted as mean ± SEM. (B) ESC
morphology after silencing INO80 subunits. (C–D) Pluripotency gene and lineage marker
expression 96 hrs after Ino80 KD. Values were plotted as mean ± SEM (E) Ino80 expression
during ESC differentiation induced by LIF-withdrawal, retinoic acid (RA) treatment, or
embryoid body (EB) formation. Expression was normalized to day-0 by β-actin and plotted
as mean ± SEM. (F) Oct4, Nanog, Sox2, Klf4 and Esrrb occupancy near the Ino80 gene
locus based on published datasets. (G) Ino80 expression 48 hrs after Oct4 or Sox2 silencing.
Expression was normalized to NT and plotted as mean ± SEM.
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Figure 2. INO80 is Required for Key Pluripotency Gene Expression
(A) Venn diagram showing gene expression changes 96 hrs after INO80 subunits KD. Blue
arrows: genes up- or down-regulated by Ino80, Ino80b, Ino80c and Ino80e silencing; red
arrows: genes inconsistently affected by Ino80, Ino80b, Ino80c or Ino80e silencing. (B)
Gene expression changes upon shRNA-mediated Ino80 silencing at the indicated time
points. Selected pluripotency genes that are significantly down-regulated in at least 2 time
points are listed. (C) GSEA showing that the Ino80 KD down-regulated genes were enriched
for genes down-regulated during ESC differentiation into EBs. (D) Hierarchical clustering
of pluripotency factors based on the gene expression changes caused by their KD. See
methods for detailed description on GSEA and the hierarchical clustering analysis. (E) Ino80
peak distribution in the genome. (F) Average ChIP-seq read density of Ino80 and other
factors near Ino80 peak center. Oct4, Nanog, Sox2, H3K4me3, H3K27ac, and H3K27me3
occupancy was based on published data. (G) Genome browser tracks to show Ino80
occupancy near Oct4, Nanog, Sox2, Klf4, Esrrb. Black bars indicate the regions (1 and 2)
selected for ChIP-qPCR verification. (H) Venn diagram showing the overlap between genes
differentially expressed after Ino80 KD and those occupied by Ino80. (I) IPA of the 678
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Ino80 target genes. Selected top categories were shown and see Table S4 for the complete
list of enriched categories.
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Figure 3. Ino80 Occupies Genomic Regions Near Pluripotency Genes
(A) Factor occupancy near genes that are expressed during ESC differentiation. Left: Heat
map showing gene expression fold-changes during EB formation at day-2 and day-9; Right:
Heat maps showing Ino80, Oct4, Nanog, Sox2, and H3K27me3 occupancy. Genes are sorted
based on Ino80 occupancy. EB differentiation, Oct4, Nanog, Sox2, and H3K27me3 ChIP-
seq data were downloaded from the GEO database. (B) GSEA for genes associated with
Ino80 occupancy. (C) Ingenuity analysis of genes co-occupied by Ino80 and the master
transcription factors (ONS) and those co-occupied by the master transcription factors but not
Ino80. (D) Interaction between Ino80 and Oct4, Wdr5. ESC lysates were sonicated and
incubated with IgG or Ino80 antibody in the presence of Benzonase to remove nucleic acid
contamination, and the presence of Oct4 and Wdr5 in the co-purified proteins were detected
by western blot. (E) Western blot showing Oct4 depletion in ZHBTc4 cells at 24 and 48 hrs
after Dox treatment. (F) Impact of Oct4 depletion on Ino80 occupancy at Oct4, Nanog, Sox2
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promoter regions. ZHBTc4 cells were treated with Dox for 48 hrs to induce Oct4 depletion,
and Ino80 occupancy was determined by ChIP-qPCRs. (G) Western blot showing Wdr5
depletion at 24 and 48 hrs after Wdr5 shRNA lentivirus transduction. (H) Impact of Wdr5
depletion on Ino80 occupancy. ESCs were transduced with Wdr5 shRNA lentivirus, and
Ino80 occupancy was determined by ChIP-qPCRs 48 hrs after transduction. (I) Overlap
between genes occupied by Ino80, Oct4, or Wdr5. Oct4 and Wdr5 occupancy was based on
published data.
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Figure 4. INO80 Promotes Mediator Recruitment at Pluripotency Gene Promoters
(A–B) Oct4, Klf4, and Med1 occupancy near TSS at Ino80-bound and Ino80-unbound
genes. Oct4, Klf4, and Med1 occupancy was based on published data. (A) Average ChIP-
seq read density. (B) Box plot of ChIP-seq read density. (C–H) Impact of Ino80 silencing on
factor occupancy. ESCs were transduced with NT- (non-targeting) or Ino80-shRNA virus
(shIno80), and factor occupancy was determined by ChIP-Seq or ChIP-qPCR 48 hrs after
transduction. (C) Average ChIP-seq read density of Oct4, Klf4, and Med1 near TSS at
Ino80-bound and Ino80-unbound genes in NT- or Ino80-shRNA virus transduced ESCs. (D)
Box plot of Oct4, Klf4, and Med1 ChIP-seq read density near TSS. p-values were calculated
between Ino80-bound and Ino80-unbound genes by Wilcoxon Rank-Sum test. (E) Average
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ChIP-seq read density of Med1 near TSS at Ino80-KD down-regulated genes. p-values were
calculated by Wilcoxon Rank-Sum test. (F) Box plot of Med1 ChIP-seq read density near
TSS at Ino80-KD down-regulated genes. p-values were calculated by Wilcoxon Rank-sum
test. (G) Genome browser tracks to show Med1 occupancy near Oct4, Nanog, Sox2, and
Klf4 in NT-or Ino80-shRNA virus transduced ESCs. Ino80 occupancy in ESCs was shown
for comparison. (H) ChIP-qPCR to show Med1 occupancy near Oct4, Nanog, Sox2, and
Klf4 TSS.
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Figure 5. INO80 Promotes Pol II Recruitment at Pluripotency Gene Promoters
(A–E) Impact of Ino80 silencing on Pol II occupancy. ESCs were transduced with NT-(non-
targeting) or Ino80-shRNA virus (shIno80), and Pol II occupancy was determined by ChIP-
Seq or ChIP-qPCR 48 hrs after transduction. (A) Average ChIP-seq read density of Pol II
near TSS at Ino80-bound and Ino80-unbound genes. p-values were calculated between
Ino80-bound and Ino80-unbound genes by Wilcoxon Rank-Sum test. (B) Box plot of Pol II
ChIP-seq read density near TSS at Ino80-bound and Ino80-unbound genes. p-values were
calculated by Wilcoxon Rank-Sum test. (C) Average ChIP-seq read density of Pol II near
TSS at Ino80-KD down-regulated genes. p-values were calculated by Wilcoxon Rank-Sum
test. (D) Box plot of Pol II ChIP-seq read density near TSS at Ino80-KD down-regulated
genes. p-values were calculated by Wilcoxon Rank-sum test. (E) ChIP-qPCR to show Pol II
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occupancy near Oct4, Nanog, Sox2, and Klf4 TSS. (F) GSEA for genes co-occupied by
Ino80, Med1, and Pol II during ESC differentiation into EBs. (G) Expression of Ino80,
Med1, and Pol II co-occupied genes during ESC differentiation into EBs. EB differentiation,
Med1, Pol II ChIP-seq datasets were downloaded from the GEO database.
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Figure 6. INO80 Maintains an Open Chromatin Structure
(A) ESCs were transduced with non-targeting (NT-) or Ino80-shRNA viruses and
nucleosome occupancy was determined 48 hrs after transduction by MNase-qPCR. Relative
occupancy was normalized to input and plotted as mean ± SEM. (B) Nucleosome
occupancies (based on published data) around Ino80 (red) or Oct4 (blue) peak center in
ESCs. (C) DNase I sensitivity assay. ESCs were transduced with non-targeting (NT) or
Ino80-shRNA lentivirus. 48 hrs after transduction, cell nuclei were isolated and treated with
the indicated amount of DNase I. The amount of uncut DNA fragments near the promoter
regions of Ino80-bound (top panel) and unbound genes (bottom panel) was determined by
qPCRs. Data were plotted as mean ± SEM. (D) Ino80 and DNase I occupancy (based on
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published data) around Ino80 peaks. Peaks are sorted based on Ino80 occupancy. (E) Left:
Average DNase I hypersensitivity ChIP-seq read density at Ino80-occupied (red) or non-
occupied (blue) regions near TSS. Right: Box plot of the average DNase I read density. (F)
Activity of DNA fragments bound (Oct4 and Esrrb) or unbound (Gfi1b and Oprd1) by Ino80
in the luciferase reporter assay. Values were normalized to the vector alone (pGL3-04) and
plotted as mean ± SEM. (G) Activity of DNA fragments bound or unbound by Ino80 in NT-
or Ino80- shRNA transduced ESCs 48 hrs after transduction. Values were normalized to NT
and plotted as mean ± SEM.
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Figure 7. INO80 is Required for Reprogramming and Blastocyst Formation
(A) Ino80 expression during somatic cell reprogramming based on RT-qPCR. Expression
was normalized by β-actin and to day-0, and plotted as mean ± SEM. (B–E) Effect of Ino80
KD on reprogramming. (B) Number of AP-positive colonies formed after reprogramming
were plotted as mean ± SEM. (C–D) Percentage of Oct4GFP-positive cells formed after
reprogramming was determined by FACS and plotted as mean ± SEM. (E) Expression of
early reprogramming markers in NT- or Ino80-shRNA transduced MEFs at day-6 of
reprogramming. (F) Ino80 expression during early embryonic development in vivo based on
RT-qPCR. Expression was normalized to 1-cell embryo and plotted as mean ± SEM. (G)
Immunofluorescence staining of Ino80 (red) and Oct4 (green) in E3.5 blastocysts. Cell
nuclei were counter stained with DAPI (blue). (H–I) Effect of Ino80 KD on blastocyst
development. (H) Morphology of embryos 4 days after siRNA injection. (I) Percentage of
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normal embryosat each developmental stage. Values were normalized to 2-cell stage and
plotted as mean ± SEM from three independent experiments. (J–K) Gene expression
analysis upon Ino80 silencing determined by RT-qPCR in the injected embryos. Expression
of normalized by β-actin and to NT siRNA injected embryos, and was plotted as mean ±
SEM.
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